Tokyo, July 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062148) titled 'Investigation of Changes in Plasma Rocuronium Concentration During Cardiopulmonary Bypass and Hemodialysis' on July 21.
Study Type:
Observational
Primary Sponsor:
Institute - Yamagata University
Condition:
Condition - Patients undergoing cardiac surgery with cardiopulmonary bypass
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To determine the extent to Which rocuronium is removed by the hemoconcentrator during cardiopulmonary bypass
Basic objectives2 - Pharmacokinetics
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients aged 20 years or older who were scheduled to undergo elective cardiac surgery with cardiopulmonary bypass were enrolled
Key exclusion criteria - Emergency operation
Patients with serum albumin < 2.0 g/dL
Target Size - 20
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 06 Month 03 Day
Anticipated trial start date - 2026 Year 07 Month 21 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071120
Disclaimer: Curated by HT Syndication.
